［1］Irfan M,Farooqi J,Hasan R.Communityacquired pneumonia［J］.Curr Opin Pulm Med，2013，19(3):198-208.
［2］Dalhoff K，Ewig S，Gideline development group.Adult patients with nosocomial pneumonia:epidemiology,diagnosis,and treatment［J］.Dtsch Arztebl Int，2013，110(38):634-640.
［3］杨志寅.现代医学科学发展中的缺憾与思考［J/CD］.中华诊断学电子杂志，2013，1（1）：1-7.
［4］杨瑞锋，管文莉，王茜，等.新型丙型肝炎病毒抗体检测试剂Elecsys antiHCV Ⅱ的性能评价与比较［J/CD］.中华诊断学电子杂志，2013，1（1）：10-18.
［5］苏生利，杨裕华.HIV新发感染检测技术研究进展［J/CD］.中华诊断学电子杂志，2013，1（1）：58-60.
［6］Cheng CW,Chien MH,Su SC,et al.New markers in pneumonia［J］.Clin Chim Acta,2013,419(4):19-25.
［7］ChristCrain M, Opal SM.Clinical review: the role of biomarkers in the diagnosis and management of communityacquired pneumonia［J］.Crit Care, 2010,14(1):203.
［8］Povoa P.Serum markers in community acquired pneumonia and ventilatorassociated pneumonia［J］.Curr Opin Infect Dis,2008,21(2):157-162.
［9］Abdeldaim GM,Stralin K,Korsgaard J,et al.Multiplex quantitative PCR for detection of lower respiratory tract infection and meningitis caused by Streptococcus pneumoniae,

Haemophilus influenzae and Neisseria meningitidis［J］.BMC Microbiol,2010,10(12):310.
［10］Louie RF,Tang Z,Albertson TE,et al.Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia［J］.Crit Care Med ,2008,36(5):1487-1492.
［11］Conway Morris A,Kefala K,Wilkinson TS,et al.Diagnostic importance of pulmonary interleukinlbeta and interleukin8 in ventilatorassociated pneumonia［J］.Thorax,

2010,65(3):201-207.
［12］Johnston P,McAuley DF,O'Kane CM.Novel pulmonary biomarkers in the diagnosis of VAP［J］.Thorax,2010,65(3):190-192.
［13］Moalli F,Jaillon S,Inforzato A,et al.Pathogen recognition by the long pentraxin PTX3［J］.J Biomed Biotechnol,2011,2011:1-15.
［14］Mantovani A, Garlanda C, Doni A, et al.Pentraxins in innate immunity: from Creactive protein to the long pentraxin PTX3［J］.J Clin Immunol ,2008,28(1):1-13.
［15］Summah H, Qu JM.Biomarkers: a definite plus in pneumonia［J］.Mediators Inflamm ,2009,2009:1-9.
［16］Coelho LM,Salluh JI，Soares M,et al.Patterns of creactive protein RATIO response in severe communityacquired pneumonia:a cohort study［J］.Crit Care,2012,16(2):R53.
［17］Huttunen R,Hurme M,Aittoniemi J,et al.High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients:a prospective cohort study

［J］.PLoS One，2011，6(3):e17653.
［18］Kao SJ,Yang HW,Tsao SM,et al.Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with communityacquired pneumonia［J］.Clin

Chem Lab Med,2013,51(4):907-913.
［19］LipinskaGediga M,Mierzchala M,Durek G.Proatrial natriuretic peptide (proANP)level in patients with severe sepsis and septic shock:prognostic and diagnostic

significance［J］.Infection,2012,40(3):303-309.
［20］Ramirez P,Garcia MA,Ferrer M,et al.Sequential measurements of procalcitonin levels in diagnosing ventilatorassociated pneumonia［J］.Eur Respir J,2008,31(2):356-362.
［21］Kruger S,Ewig S，Marre R,et al.Procalcitonin predicts patients at low risk of death from communityacquired pneumonia across all CRB65 classes［J］.Eur Respir

J,2008,31(2):349-355.
［22］ChristCrain M,Stolz D,Bingisser R,et al.Procalcitonin guidance of antibiotic therapy in communityacquired pneumonia:a randomized trial［J］.Am J Respir Crit Care

Med,2006,174(1):84-93.
［23］Zudaire E, PortalNunez S, Cuttitta F.The central role of adrenomedullin in host defense［J］.J Leukoc Biol,2006,80(2):237-244.
［24］Oudhuis GJ, Beuving J, Bergmans D, et al.Soluble Triggering Receptor Expressed on Myeloid cells1 in bronchoalveolar lavage fluid is not predictive for

ventilatorassociated pneumonia［J］.Intensive Care Med,2009,35(7):1265-1270.
［25］Anand NJ, Zuick S, KlesneyTait J,et al.Diagnostic implications of soluble triggering receptor expressed on myeloid cells1 in BAL fluid of patients with pulmonary

infiltrates in the ICU［J］.Chest,2009,135(3):641-647.
［26］Katan M, ChristCrain M.The stress hormone copeptin: a new prognostic biomarker in acute illness［J］.Swiss Med Wkly, 2010,140:w13101.
［27］Nickel CH, Bingisser R, Morgenthaler NG.The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department［J］.BMC

Med,2012,10(1):1-7.
［28］Land H, Schutz G, Schmale H,et al.Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressinneurophysin II precursor［J］.Nature ,1982,295(5847):299-303.
［29］Morgenthaler NG, Struck J, Alonso C,et al.Assay for the measurement  of copeptin, a stable peptide derived from the precursor of vasopressin［J］.Clin Chem ,2006,52(1):112

-119.
［30］Muller B, Morgenthaler N, Stolz D, et al.Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections［J］.Eur J Clin Invest,2007,37(2):145-152.
［31］Dubey A, Boujoukos AJ.Measurements of serum free cortisol in critically ill patients［J］.Crit Care ,2004,9(1):E2.
［32］ChristCrain M,Stolz D,Jutla S,et al.Free and total cortisol levels as predictors of severity and outcome in communityacquired pneumonia［J］.Am J Respir Crit Care

Med,2007,176(9):913-920.
［33］Kolditz M, Hoffken G, Martus P, et al.Serum cortisol predicts death and critical disease independently of CRB65 score in communityacquired pneumonia: a prospective

observational cohort study［J］.BMC Infect Dis ,2012,12(4):90.
［34］龚裕强，孙来芳,曾潍贤，等.成人重症肺炎患者心肌损伤标志物和心功能变化特点［J］.中国急救复苏与灾难医学杂志，2011，6（7）：613-615.
［35］李新丰，黎冉，王高雄，等.呼吸频率及潮气量对老年CO2气腹患者呼吸功能及胃黏膜pH值变化的预测价值［J/CD］.中华诊断学电子杂志，2014，2（1）：44-46.
［36］杨志寅.现代医学科学发展中的缺憾与思考［J/CD］.中华诊断学电子杂志，2013，1（1）：1-7.
［37］潘祥林，王鸿利.诊断学的任务与发展方向［J/CD］.中华诊断学电子杂志，2013，1（1）：8-9.